News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Netflix shares are down over 50% from highs, trading near $63 with mid‑teens P/E and producing free cash flow.
  • Some investors recommend buying Netflix's pullback with defined stops and a multi‑month horizon.
  • Bitcoin traded above $76,000 as cryptocurrency prices showed tentative stabilization.
  • Large net redemptions from U.S. spot Bitcoin ETFs underscore that institutional demand remains fragile.
  • Broader crypto markets were mixed, with Ether and several altcoins up while XRP lagged.

Latest Articles

BCA Research: Opportunity Emerging for Gold as Near-Term Headwinds Ease

BCA Research: Opportunity Emerging for Gold as Near-Term Headwinds Ease

BCA Research told clients that gold's recent decline is showing signs of exhaustion and that the tactical obstacles to higher prices are diminishing. The firm highlights real interest rates and the U.S. dollar as the primary drivers of gold, says central bank buying now offers a price floor, and recommends a long position as the worst of the pullba…

Netcapital Provides Update on SEC Stay

Netcapital Provides Update on SEC Stay

Netcapital Inc. reports that the SEC has stayed the recently approved Nasdaq rule requiring companies with market value of listed securities (MVLS) below $5 million to face immediate delisting. The full SEC Commission will review the rule, currently suspended, providing Netcapital and other small-cap Nasdaq companies more time to focus on turnaroun…

Nasdaq Resumes Trading in Jiade Limited

Nasdaq Resumes Trading in Jiade Limited

Trading in Jiade Limited's Class A Ordinary Shares, which had been halted on June 4, 2026, resumed on July 31, 2026 at 12:00 p.m. Eastern Time on the Nasdaq stock exchange. The announcement comes directly from Nasdaq with no specific reasons or additional details provided about the resumption or prior trading halt.

Shaboozey’s “Outlaw” Is Wanted in Every Record Store in America

Shaboozey’s “Outlaw” Is Wanted in Every Record Store in America

Alliance Entertainment Holding Corporation, via its AMPED Distribution division, is orchestrating a comprehensive nationwide retail marketing campaign for Shaboozey’s new album 'The Outlaw Cherie Lee & Other Western Tales.' The campaign integrates independent record stores, major retailers, and e-commerce platforms, featuring listening parties, exc…

Cerenome Launches as an Integrated CNS Oncology Company

Cerenome Launches as an Integrated CNS Oncology Company

Plus Therapeutics, Inc. is rebranding as Cerenome, Inc., with a new Nasdaq ticker CNSY, reflecting its transformation into an integrated central nervous system (CNS) oncology company. Cerenome aims to combine precision diagnostics (CNSide®), targeted radiotherapeutics (REYOBIQ™), and proprietary data analytics powered by artificial intelligence to …

Vistagen Appoints Douglas J. Williamson to its Board of Directors

Vistagen Appoints Douglas J. Williamson to its Board of Directors

Vistagen Therapeutics, a late clinical-stage biopharmaceutical company specializing in intranasal neurocircuitry-focused treatments, announced the appointment of Douglas J. Williamson, MD, to its Board of Directors. Dr. Williamson brings extensive experience in neuroscience drug development and regulatory approvals, expected to strengthen Vistagen'…

Nasdaq Resumes Trading in Inno Holdings Inc.

Nasdaq Resumes Trading in Inno Holdings Inc.

The Nasdaq Stock Market has resumed trading of Inno Holdings Inc. (INHD) at noon on July 31, 2026, following a trading halt that began on June 8, 2026. The reason for the halt was not disclosed in the announcement. Investors can now trade the company’s shares again on Nasdaq.

Cycurion Announces a Warrant Inducement Transaction for $4.5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Cycurion Announces a Warrant Inducement Transaction for $4.5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Cycurion, a Nasdaq-listed cybersecurity and AI solutions provider, has entered into a warrant inducement transaction with an institutional investor, raising approximately $4.5 million in gross proceeds through the immediate exercise of warrants. In return, the investor receives new warrants to purchase additional shares at a higher exercise price, …

Acciona Shares Drop After H1 Results Reveal Sharply Lower Profitability

Acciona Shares Drop After H1 Results Reveal Sharply Lower Profitability

Acciona's shares fell about 3% after the company reported an 84.3% year-on-year decline in attributable net profit for the first half of 2026, driven by the lack of asset rotation gains that lifted H1 2025 and a swing to a loss at its renewable subsidiary. Management points to July asset disposals and a stronger second half, but investors and analy…

Colgate-Palmolive Holds Annual Sales Outlook as North American Demand Slips

Colgate-Palmolive Holds Annual Sales Outlook as North American Demand Slips

Colgate-Palmolive reaffirmed its full-year net sales guidance after reporting a quarterly sales increase, even as organic sales in North America declined. The company cited volume weakness, market share pressure and inventory reductions at major retailers, while warning that new U.S. tariffs will more than offset recent tariff refunds. Adjusted pro…

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced a technological milestone for their quantum sampling workflow platform, demonstrating a complete end-to-end hybrid quantum-classical analytical process for clinical trial data analytics. This advancement supports processing high-dimensional biomedical datasets with enha…